Alpha Tau Medical Ltd. Ordinary Shares
DRTSStock
$11.88+282.04%52W
Market Cap$1.10B
P/E—
Div yield—
Beta1.17
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)102.63%
Price vs S&P 500 (4W)28.01%
VGM Score86.74
Market Capitalization$1.10B
Earnings Surprise History
Q1 26-0.26est. -0.13
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.20
4.20
4.18
4.18
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DRTSAlpha Tau Medical Ltd. Ordinary Shares | — | — | A | $11.88 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Alpha Tau Medical is a clinical-stage oncology company developing Alpha DaRT, a proprietary technology that harnesses alpha particles for localized radiation therapy to treat solid tumors. The technology leverages alpha particles' therapeutic properties while addressing their traditionally limited range. The company is advancing its clinical pipeline with operations based in Israel.